Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
International Journal of Traditional Chinese Medicine ; (6): 1071-1074, 2019.
Article in Chinese | WPRIM | ID: wpr-797171

ABSTRACT

Objective@#To evaluate the efficacy of Tenghuang-Jiangu tablet combined with osteopeptide injection in the treatment of lumbar hyperosteogeny.@*Methods@#A total of 106 patients with lumbar hyperosteogeny were randomly divided into two groups, 53 in each group by digital table method. The control group was treated with osteopeptide injection, and the study group was treated with Tenghuang-Jiangu tablet on the basis of the control group. Both groups were treated for 45 days. The traditional Chinese medcine (TCM) symptoms were scored from pain, numbness, swelling, flexion and extension before and after treatment. The levels of thromboxane B2 (TXB2) and 6-ketone prostaglandin Flα ( 6-Keto-PGFlα ) in serum were detected by ELISA. Adverse reactions during treatment were recorded.@*Results@#The total effective rate was 86.8% (46/53) in the study group and 64.2% (34/53) in the control group. There were significant differences between the two groups (χ2=7.338, P=0.007). After treatment, the serum TXB2 (128.01 ± 23.68 pg/ml vs. 172.26 ± 19.33 pg/ml, t=10.539) level in the study group was significantly lower than control group (P<0.01); the serum 6-Keto-PGFlα (36.84 ± 4.96 pg/ml vs. 25.44 ± 4.21 pg/ml, t=12.757) level was significantly higher than control group (P<0.01). After treatment, the scores of pain, numbness, swelling, flexion and extension in the study group were significantly lower than those in the control group (t=10.061, 11.449, 14.921, 15.527, P<0.01). During the treatment period, the incidence of adverse reactions was 17.0% (9/53) in the control group and 22.6% (12/53) in the study group. There was no significant difference between the two groups (χ2=0.534, P=0.465).@*Conclusions@#The Tenghuang-Jiangu tablet combined with osteopeptide injection can improve the clinical symptoms of patients with lumbar hyperosteogeny, and regulate the serum levels of TXB2 and 6-Keto-PGFlα.

2.
International Journal of Traditional Chinese Medicine ; (6): 1071-1074, 2019.
Article in Chinese | WPRIM | ID: wpr-751829

ABSTRACT

Objective To evaluate the efficacy of Tenghuang-Jiangu tablet combined with osteopeptide injection in the treatment of lumbar hyperosteogeny. Methods A total of 106 patients with lumbar hyperosteogeny were randomly divided into two groups, 53 in each group by digital table method. The control group was treated with osteopeptide injection, and the study group was treated with Tenghuang-Jiangu tablet on the basis of the control group. Both groups were treated for 45 days. The traditional Chinese medcine (TCM) symptoms were scored from pain, numbness, swelling, flexion and extension before and after treatment. The levels of thromboxane B2 (TXB2) and 6-ketone prostaglandin Flα ( 6-Keto-PGFlα ) in serum were detected by ELISA. Adverse reactions during treatment were recorded. Results The total effective rate was 86.8% (46/53) in the study group and 64.2% (34/53) in the control group. There were significant differences between the two groups (χ2=7.338, P=0.007). After treatment, the serum TXB2 (128.01 ± 23.68 pg/ml vs. 172.26 ± 19.33 pg/ml, t=10.539) level in the study group was significantly lower than control group (P<0.01); the serum 6-Keto-PGFlα (36.84 ± 4.96 pg/ml vs. 25.44 ± 4.21 pg/ml, t=12.757) level was significantly higher than control group (P<0.01). After treatment, the scores of pain, numbness, swelling, flexion and extension in the study group were significantly lower than those in the control group (t=10.061, 11.449, 14.921, 15.527, P<0.01). During the treatment period, the incidence of adverse reactions was 17.0% (9/53) in the control group and 22.6% (12/53) in the study group. There was no significant difference between the two groups (χ2=0.534, P=0.465). Conclusions The Tenghuang-Jiangu tablet combined with osteopeptide injection can improve the clinical symptoms of patients with lumbar hyperosteogeny, and regulate the serum levels of TXB2 and 6-Keto-PGFlα.

3.
Chongqing Medicine ; (36): 3881-3882,3886, 2013.
Article in Chinese | WPRIM | ID: wpr-598680

ABSTRACT

Objective To investigate the relationship between MRI signal type and CT structural characteristics on lumbar hy-perostogeny ,and the possible mechanism of vertebral body remodeling on degenerative lumbar spine .Methods Imaging data of for-ty-five subjects who were referred for both MRI and CT imaging of the lumbar spine from July 2011 to January 2012 were retro-spectively analyzed .Volume Rendering(VR) and Multi-Planar Reformation(MPR) were used to observe structural characteristics of osteophyte .Osteophyte formation ,MRI signal type and CT features of osteophyte were recorded ,then analyzed their relationship . Results 45 subjects contain 225 vertebral bodies ,there were 38 vertebral bodies containing osteophyte visible to naked eye .The four types of MRI signal were type Ⅰ to type Ⅳ ,accounting for 2(5 .3% ) ,4(10 .5% ) ,10(26 .3% ) and 22(57 .9% ) ,respectively . The three types of CT structural characteristics are type A to type C ,accounting for 4(10 .5% ) ,11(28 .9% ) and 23(60 .5% ) ,re-spectively .The main MRI signal of type A is type Ⅱ(100% ) ,and that of type B and C are both type Ⅳ(72 .7% and 65 .2% ) .Con-clusion There is a corresponding relation between MRI signal type and CT structural characteristics on lumbar hyperostogeny . Constant reconstruction of osteophyte remodels vertebral body on degenerative lumbar spine .

SELECTION OF CITATIONS
SEARCH DETAIL